Wayback Machine
Nov DEC Jan
Previous capture 19 Next capture
2014 2015 2016
1 captures
19 Dec 15 - 19 Dec 15
sparklines
Close Help

Summary

Percutaneous coronary intervention is the primary treatment for patients with acute coronary syndrome. Selective use of manual thrombectomy may be an effective option. P2Y12 inhibitors are a treatment of choice in patients with STEMI. Bivalirudin reduces adverse cardiac events and is associated with reduced bleeding. When percutaneous coronary intervention is delayed in patients with STEMI, fibrinolytic therapy should be administered.

  • acute coronary syndrome
  • bivalirudin
  • fibrinolytic therapy
  • glycoprotein IIb/IIIa
  • Impella
  • intraaortic balloon pump
  • P2Y12 inhibitors
  • NSTEMI
  • percutaneous coronary intervention
  • pharmacoinvasive
  • STEMI
  • thrombin inhibitor
  • pharmacology
  • cardiology & cardiovascular medicine guidelines
  • interventional techniques & devices
View Full Text